RAW 264.7（單核巨噬細(xì)胞白血病）   
產(chǎn)品品牌：ATCC
價(jià)格：詢(xún)價(jià)
上海研生生化試劑有限公司是一家專(zhuān)業(yè)經(jīng)營(yíng)ELISA 試劑盒、放免試劑盒、儀器耗材、科研細(xì)胞株的公司。 本產(chǎn)品RAW 264.7（單核巨噬細(xì)胞白血病）相關(guān)詳細(xì)信息請(qǐng)。
產(chǎn)品說(shuō)明：
This line was established from a tumor induced by Abelson murine leukemia virus. This line does not secrete detectable virus particles and is negative in the XC plaque formation assay. They are negative for surface immunoglobulin （sIg-）, Ia （Ia-） and Thy-1.2 （Thy-1.2-）. The cells will pinocytose neutral red and will phagocytose latex beads and zymosan. They are capable of antibody dependent lysis of sheep erythrocytes and tumor cell targets. LPS or PPD treatment for 2 days stimulates lysis of erythrocytes but not tumor cell targets
相關(guān)產(chǎn)品：
 
P19（畸胎癌細(xì)胞） 
C6（膠質(zhì)瘤細(xì)胞） 
RBL-2H3（白血病細(xì)胞） 
SiHa（子宮頸癌細(xì)胞）